AMNEAL PHARMACEUTICALS INC (AMRX) Institutional Ownership and Insiders Activity
AMNEAL PHARMACEUTICALS INC (AMRX) is widely held by institutional investors, with 299 firms reporting positions valued at approximately $2.80B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $459.79M in AMRX holdings in its latest filing.
Recent insider activity includes 13 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
299
Total Reported Value
$2.80B
Largest Holder
Blackrock, Inc.
Largest Position
$459.79M
Insider Transactions (90d)
13
Latest Filing Quarter
Q2 2026
New Institutional Positions
47
Funds Exiting Positions
59
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$459.79M
- Tpg Gp A, Llc$213.41M
- Vanguard Portfolio Management Llc$210.10M
- Rubric Capital Management Lp$176.02M
- Vanguard Capital Management Llc$133.46M
AMRX News
All news- Nantahala Capital Management Q3 2026 Investment Activity
Aug 20, 2026 · valut.ai
- Phocas Financial Corp Portfolio Changes Q2 2026: Strategic Shifts in Banks and Biotech
Aug 3, 2026 · valut.ai
Related AMRX Institutional Insights:
- AMRX 13F Institutional Holders
- AMRX Top Institutional Shareholders
- AMRX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- AMRX Insider Trading & SEC Form 4 Activity
- AMRX Articles
- Top Institutional Investor Stock Rankings